BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

M Xing - Endocrine reviews, 2007 - academic.oup.com
… Direct association of BRAF mutation with the clinical … The BRAF mutation has even
been correlated with PTC … Some molecular mechanisms determining BRAF mutation-promoted …

[PDF][PDF] Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma

JL Curry, CA Torres-Cabala, MT Tetzlaff… - … medicine and surgery, 2012 - researchgate.net
… to analyze BRAF mutation status in formalin-fixed paraffin-embedded tumor samples. The
cobas Mutation Test has been designed specifically to detect BRAF V600E mutations, and the …

Biochemical and molecular characterization of the novel BRAFV599Ins mutation detected in a classic papillary thyroid carcinoma

S Moretti, A Macchiarulo, V De Falco, N Avenia, F Barbi… - Oncogene, 2006 - nature.com
BRAF mutation, namely a 1795GTT insertion, resulting in BRAF V599Ins , and describe its
biochemical and molecular … of the molecular basis responsible for the activation of BRAF

BRAFV600E: Implications for Carcinogenesis and Molecular Therapy

ER Cantwell-Dorris, JJ O'Leary, OM Sheils - Molecular cancer therapeutics, 2011 - AACR
BRAF pathway has become a target of interest for molecular therapy, with promising results
emerging from clinical trials. Here, the role of the most common BRAF mutation BRAF … -base

Mutations of the BRAF gene in human cancer

H Davies, GR Bignell, C Cox, P Stephens, S Edkins… - Nature, 2002 - nature.com
… a single base substitution to glutamic acid, yet mutations at this … These data suggest that
BRAF V599 mutations uncouple … BRAF V599 mutants can be even further activated by mutant

BRAF mutation testing in clinical practice

J Ziai, P Hui - Expert review of molecular diagnostics, 2012 - Taylor & Francis
… , with its 3 end complementary to the base immediately 3 to the nucleotide of interest. Primer
extension with labeled nucleotides can then proceed if a mutated base is present or absent, …

[HTML][HTML] Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma

WO Greaves, S Verma, KP Patel, MA Davies… - The Journal of Molecular …, 2013 - Elsevier
… V600E) mutation. However, a subset of melanomas harbor non-p.V600E BRAF mutations, …
To better understand the BRAF mutation profile in melanomas, we retrospectively analyzed …

[HTML][HTML] BRAF gene: From human cancers to developmental syndromes

MRM Hussain, M Baig, HSA Mohamoud… - Saudi journal of …, 2015 - Elsevier
BRAF gene and other members of RAS/RAF cascade in human cancers and RAS/MAPK
syndromes, and focuses the molecular basis and clinical genetics of BRAF … no BRAF mutations

[HTML][HTML] Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine

L Cheng, A Lopez-Beltran, F Massari, GT MacLennan… - Modern Pathology, 2018 - Elsevier
… Targeted therapy with BRAF and MEK inhibitors is associated with significant long-term …
patients with BRAF V600-mutated melanoma. Therefore, molecular testing for BRAF mutations is …

Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma

IV Fedorenko, KHT Paraiso, KSM Smalley - Biochemical pharmacology, 2011 - Elsevier
… of mutated BRAF in the development and progression of melanoma as the basis for
understanding the mechanism of action of BRAF … development of small molecule BRAF inhibitors. …